Scientific Publications Citizens of Science
In our quest to invent life-transforming medicines for people with serious diseases, we encourage our colleagues to publish their research in leading scientific journals.
Featured Publications
- Early-Stage Research
- Clinical Research
Cardiovascular & Renal
Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primates
Published in PLoS One. 2022 Jun 16;17(6):e0269749. doi: 10.1371/journal.pone.0269749. eCollection 2022.
General Medicine
Speed and need: twin development challenges in rapid response for a SARS-CoV-2 antibody cocktail
Published in Curr Opin Biotechnol. 2022 Mar 15;76:102715. doi: 10.1016/j.copbio.2022.102715. Online ahead of print.
Immunology & Inflammation
A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma
Published in Nat Cancer. 2022 Jun 6. doi: 10.1038/s43018-022-00391-0. Epub ahead of print.
Rare Diseases
ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
Published in J Clin Invest. 2022 May 5:e153792. doi: 10.1172/JCI153792
Technology
Activity-Based Protein Profiling Probe for the Detection of Enzymes Catalyzing Polysorbate Degradation
Published in Anal Chem. 2022 Jun 9. doi: 10.1021/acs.analchem.2c00059. Online ahead of print.
Ultrasensitive disulfide scrambling analysis of mAbs by LC-MS with post-column reduction and glycine signal enhancement
Published in Anal Biochem. 2022 Jun 7:114773. doi: 10.1016/j.ab.2022.114773. Online ahead of print.
General Medicine
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Published in Circulation. 2022 Jun 30:101161CIRCULATIONAHA121057807. doi: 10.1161/CIRCULATIONAHA.121.057807. Online ahead of print.
Hematology
Odronextamab, a human CD20xCD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial
Published in Lancet Haematol. 2022;S2352-3026(22)00072-2. doi:10.1016/S2352-3026(22)00072-2
Immunology & Inflammation
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
Published in Dermatol Ther (Heidelb). 2022 May 11. doi: 10.1007/s13555-022-00731-z. Online ahead of print.
Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP
Published in J Allergy Clin Immunol Pract. 2022 May 23:S2213-2198(22)00501-3. doi: 10.1016/j.jaip.2022.05.013. Online ahead of print.
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
Published in J Allergy Clin Immunol Pract. 2022 May 27:S2213-2198(22)00507-4. doi: 10.1016/j.jaip.2022.05.019. Online ahead of print.
Oncology
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression
Published in Ther Adv Med Oncol. 2022 Jun 16;14:17588359221105024. doi: 10.1177/17588359221105024. eCollection 2022.
Ophthalmology
Functional outcomes of sustained improvement on Diabetic Retinopathy Severity Scale with intravitreal aflibercept in the VISTA and VIVID trials
Published in Eye (Lond). 2022 Apr 19. doi: 10.1038/s41433-022-02058-7. Online ahead of print.